Ebselen

Ebselen

SCHEMBL19064566

O=c1c2ccccc2[se]n1-c1ccccc1.[PbH2]

nearest known ligand 0.96

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 5/20 0.96
▸ KDM4E B2RXH2 1/20 0.96
▸ MEN1 O00255 1/20 0.96
▸ QSOX1 O00391 1/20 0.96
▸ RGS12 O14924 1/20 0.96
▸ PMM2 O15305 1/20 0.96
▸ PLIN1 O60240 1/20 0.96
▸ GMNN O75496 1/20 0.96
▸ BBOX1 O75936 1/20 0.96
▸ ALDH1A1 P00352 1/20 0.96
▸ LMNA P02545 1/20 0.96
▸ TP53 P04637 1/20 0.96
▸ CYBB P04839 1/20 0.96
▸ BCHE P06276 1/20 0.96
▸ GLA P06280 1/20 0.96
▸ POLB P06746 1/20 0.96
▸ CYP3A4 P08684 1/20 0.96
▸ CYP2D6 P10635 1/20 0.96
▸ MAPT P10636 1/20 0.96
▸ G6PD P11413 1/20 0.96

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ebselen SCHEMBL29370082 0.98 METAP2 (1.00) METAP2KDM4EMEN1QSOX1RGS12
Ebselen SCHEMBL33829 0.98 METAP2 (1.00) METAP2KDM4EMEN1QSOX1RGS12
Ebselen SCHEMBL4406056 0.98 METAP2 (1.00) METAP2KDM4EMEN1QSOX1RGS12
Ebselen SCHEMBL20678555 0.96 METAP2 (0.96) METAP2KDM4EMEN1QSOX1RGS12
Ebselen SCHEMBL20477111 0.96 METAP2 (0.96) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL193047 0.87 METAP2 (0.79) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL28783439 0.85 METAP2 (0.77) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL10501092 0.84 METAP2 (1.00) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL1354655 0.84 METAP2 (0.74) METAP2KDM4EMEN1QSOX1RGS12
SCHEMBL30573255 0.84 METAP2 (0.74) METAP2KDM4EMEN1QSOX1RGS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10301664-B2 Repurposing non-antimicrobial drugs and clinical molecules to treat bacterial infections PURDUE RESEARCH FOUNDATION (US) 2019-05-28 — — US disclosed
US-20170189556-A1 REPURPOSING NON-ANTIMICROBIAL DRUGS AND CLINICAL MOLECULES TO TREAT BACTERIAL INFECTIONS PURDUE RESEARCH FOUNDATION (US) 2017-07-06 — — US disclosed
Send feedback